Information  X 
Enter a valid email address

Kape Technologies (KAPE)


Friday 01 October, 2021

Kape Technologies

Results of General Meeting and Total Voting Rights

RNS Number : 7722N
Kape Technologies PLC
01 October 2021

1 October 2021


Kape Technologies plc

("Kape" or the "Group")


Results of General Meeting and Total Voting Rights


Further to the Company's announcements of 13 September 2021 and 15 September 2021, Kape (AIM: KAPE), the digital security and privacy software business, announces that all resolutions proposed at the general meeting held earlier today were duly passed.


Further to the passing of Resolution 1, application has been made for 76,543,209 new Ordinary Shares of US$0.0001 each ("Ordinary Shares") to be issued pursuant to the placing and the retail offer (the "Fundraising Shares"), to be admitted to trading on the AIM market of the London Stock Exchange and it is expected that admission will take place and trading in the Fundraising Shares will commence on 4 October 2021 ("Admission").


The total number of votes received on each resolution were as follows:



Votes For

% of Votes

Votes Against

% of Votes

Total Votes

Votes cast as % of voting rights

Votes Withheld

Authority to allot the Consideration Shares and the Fundraising Shares








Refreshed general authority to allot Ordinary Shares








Refreshed general dis-application of pre-emption rights









1.  Any proxy appointments which gave discretion to the Chairman have been included in the "for" total.

2.  As at 5.00 p.m. on 13 September 2021, the Company's issued share capital at the date of the meeting was 234,421,458 Ordinary Shares. There are now 9 ,820,501 Ordinary Shares held in treasury and 600,000 Ordinary Shares held by the Kape Technologies Plc Employee Benefit Trust, the voting rights to which have been waived. Therefore, the total number of voting rights at the date of the meeting was 224,000,984.

Total Voting Rights

Following Admission of the Fundraising Shares, the total number of voting rights in Kape will be 300,544,193,  which is the figure which should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Ordinary Shares under the FCA's Disclosure and Transparency Rules.  

The Company holds 9,820,501 Ordinary Shares in treasury and the Kape Technologies plc Employee Benefit Trust holds 600,000 Ordinary Shares, the voting rights to which have been waived. Therefore, following Admission of the Fundraising Shares , the Company's issued share capital will consist of 310,964,694 Ordinary Shares.





Kape Technologies plc

Ido Erlichman, Chief Executive Officer

Moran Laufer, Chief Financial Officer



 via Vigo Consulting

Shore Capital (Nominated Adviser & Joint Broker)

Simon Fine / Toby Gibbs / Mark Percy / James Thomas / Michael McGloin


 +44 (0)20 7408 4090

Stifel (Joint Broker)

Alex Price / Brad Topchik / Alain Dobkin / Richard Short


 +44 (0) 20 7710 7600

Vigo Consulting (Financial Public Relations)

Jeremy Garcia / Antonia Pollock

[email protected]

 +44 (0)20 7390 0237


About Kape


Kape is a leading 'privacy-first' digital security software provider to consumers. Through its range of privacy and security products, Kape focuses on protecting consumers and their personal data as they go about their daily digital lives.

To date, Kape has over 2.7 million paying subscribers, supported by a team of over 430 people across eight locations worldwide. Kape has a proven track record of revenue and EBITDA growth, underpinned by a strong business model which leverages our digital marketing expertise.

Through its subscription-based platform, Kape has fast established a highly scalable SaaS-based operating model, geared towards capitalising on the vast global consumer digital privacy market.

Twitter LinkedIn

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t